Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.

Personal Medication and Health Management (PM&HM), a Russia-based connected inhaler system developer based on Russian Academy of Sciences research, has received 305m rubles ($4.6m) of funding, according to East-West Digital News. The capital came from the National Technology Initiative Support Fund, an investment vehicle established by Russian government-owned fund-of-funds RVC. PM&HM is developing a digitally-enabled…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.